Angiœdèmes par déficit acquis en C1-inhibiteur : recommandations du CREAK pour le diagnostic et la prise en charge
- 2 August 2020
- journal article
- research article
- Published by Elsevier BV in La Revue de Médecine Interne
- Vol. 41 (12), 838-842
- https://doi.org/10.1016/j.revmed.2020.06.010
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrateOrphanet Journal of Rare Diseases, 2019
- Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialThe Lancet, 2017
- A nationwide study of acquired C1-inhibitor deficiency in FranceMedicine, 2016
- Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatmentAnnals of Medicine, 2016
- High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiencyBritish Journal of Haematology, 2016
- The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunitycclm, 2016
- Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedemaEuropean Journal of Dermatology, 2014
- Hereditary angio-oedemaThe Lancet, 2012